European Pharmaceutical Pricing and Reimbursement Conference 2015
October 5 - 6, 2015
Лондон , Великобритания
SMi's 21st annual European Pharmaceutical Pricing & Reimbursement conference, taking place on 5-6 October 2015 in London, will bring together senior industry figures from big pharma, biotech and academia discussing recent updates and highlighting strategies to deal with the latest P&R developments through keynote addresses, case studies and roundtable discussions. International changes in policy will also be highlighted, along with an in-depth focus on biosimilar dugs and the impact that they have had on P&R through nations across Europe.
Benefits of attending:
- Evaluate new models for European reimbursement
- Develop understanding of tiered pricing options with case studies from GSK
- Gain further insight into current HTA policies
- Receive invaluable information from field leaders through in-depth case studies
- Learn about changes in UK P&R policy following the UK elections from industry bodies EMIG and the ABPI
Speaker Panel includes:
- Leslie Galloway, Chairman, Ethical Medicines Industry Group
- Alexander Natz, Secretary General, European Confederation of Pharmaceutical Entrepreneurs
- Janice Haigh, Practice Leader Market Access, Quintiles
- Ken Walsh, Head Emerging Markets Pricing, GSK
- Toros Sahin, Head of Market Access & Health Economics, Sanofi Turkey
- David Watson, Director of Pricing & Reimbursement, ABPI
- Alexander Roediger, Director European Union Affairs, MSD
- Leyla Hannbeck, Head of Pharmacy, National Pharmaceutical Association Ltd
- Eric Low, CEO, Myeloma UK
The conference will also feature an interactive post-conference workshop on: HTA Uncovered, led by Anke Van Engen, Chief Development Officer and Janice Haigh, Practice Leader Market Access, Quintiles, taking place on the 7th October 2015 in London.
Benefits of attending:
- Evaluate new models for European reimbursement
- Develop understanding of tiered pricing options with case studies from GSK
- Gain further insight into current HTA policies
- Receive invaluable information from field leaders through in-depth case studies
- Learn about changes in UK P&R policy following the UK elections from industry bodies EMIG and the ABPI
Speaker Panel includes:
- Leslie Galloway, Chairman, Ethical Medicines Industry Group
- Alexander Natz, Secretary General, European Confederation of Pharmaceutical Entrepreneurs
- Janice Haigh, Practice Leader Market Access, Quintiles
- Ken Walsh, Head Emerging Markets Pricing, GSK
- Toros Sahin, Head of Market Access & Health Economics, Sanofi Turkey
- David Watson, Director of Pricing & Reimbursement, ABPI
- Alexander Roediger, Director European Union Affairs, MSD
- Leyla Hannbeck, Head of Pharmacy, National Pharmaceutical Association Ltd
- Eric Low, CEO, Myeloma UK
The conference will also feature an interactive post-conference workshop on: HTA Uncovered, led by Anke Van Engen, Chief Development Officer and Janice Haigh, Practice Leader Market Access, Quintiles, taking place on the 7th October 2015 in London.
Место проведения
Location: Holiday Inn Regents Park London
Обратная связь
Twickenham , United Kingdom
Организатор
SMi Group Ltd
2nd Floor South, Harling House
47-51 Great Suffolk Street
London
SE1 0BS
United Kingdom
+44 (0) 20 7827 6000
Похожие мероприятия
European Pharmaceutical Pricing and Reimbursement Conference October 5 - 6, 2015
European Pharmaceutical Pricing and Reimbursement Conference October 13 - 14, 2014
European Pharmaceutical Pricing and Reimbursement Conference October 29 - 30, 2012
European Pharmaceutical Pricing and Reimbursement Conference October 31 - November 1, 2011
European Pharmaceutical Pricing and Reimbursement Conference October 27 - 28, 2010